Protection of FK506 against neuronal apoptosis and axonal injury following experimental diffuse axonal injury

Diffuse axonal injury (DAI) is the most common and significant pathological features of traumatic brain injury (TBI). However, there are still no effective drugs to combat the formation and progression of DAI in affected individuals. FK506, also known as tacrolimus, is an immunosuppressive drug, whi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ting-Qin, Song, Jin-Ning, Zheng, Feng-Wei, Pang, Hong-Gang, Zhao, Yong-Lin, Gu, Hua, Zhao, Jun-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428482/
https://www.ncbi.nlm.nih.gov/pubmed/28339015
http://dx.doi.org/10.3892/mmr.2017.6350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428482/
https://www.ncbi.nlm.nih.gov/pubmed/28339015
http://dx.doi.org/10.3892/mmr.2017.6350

Ejemplares similares